Keith Orford - 05 Nov 2021 Form 4 Insider Report for Calithera Biosciences, Inc.

Role: Director
Signature: /s/ Keith Orford
Issuer symbol: CALA on OTC
Transactions as of: 05 Nov 2021
Net transactions value: -$43,520
Form type: 4
Filing time: 09 Nov 2021, 18:39:21 UTC
Previous filing: 29 Oct 2021
Next filing: 12 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CALA	Common Stock	Award	$0	+30,000	+18%	$0.000000	196,094	05 Nov 2021	Direct	F1
transaction	CALA	Common Stock	Sale	$43,520	-51,810	-26%	$0.8400	144,284	09 Nov 2021	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of Common Stock were acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.832 to $0.850424, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Content

The shares of Common Stock were acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.832 to $0.850424, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.